Page 65 - NATIONAL INSTITUTES OF HEALTH (NIH) GUIDELINES FOR CONDUCTING RESEARCH IN MINISTRY OF HEALTH (MOH) INSTITUTIONS & FACILITIES 3RD EDITION 2021
P. 65

Initial Submission prior to the study commencement
                         During this planning stage the following documents should be generated and
                                         should be on file of investigators

                            Document                              Purpose
             1.   INVESTIGATOR’S BROCHURE      To document that investigator is informed in a timely manner
                  UPDATES (where applicable)   of relevant information as it becomes available
             2.   ANY REVISION TO:             To document revisions of these trial related documents that
                  -  protocol/amendment(s) and CRF  take effect during trial/research
                  -  informed consent form
                  -  any other written information
                   provided to subjects
                  -  advertisement for subject
                   recruitment (if used)
             3.   DATED, DOCUMENTED            To document that the amendment(s) and/or revision(s) have
                  APPROVAL/FAVOURABLE          been subject to IRB/IEC review and were given approv-al/
                  OPINION OF INSTITUTIONAL     favourable opinion. To identify the version number and date of
                  REVIEW BOARD (IRB) /         the document(s)
                  INDEPENDENT ETHICS
                  COMMITTEE (IEC) OF THE
                  FOLLOWING (where applicable) :
                  -  protocol amendment(s)
                  -  revision(s) of:
                  -  informed consent form
                  -  any other written information to be
                   provided to the subject
                  -  advertisement for subject
                   recruitment (if used)
                  -  any other documents given
                   approval/favorable opinion
             4.   REGULATORY                   To update whenever changes to investigators have been
                  AUTHORITY(IES)               approved via amendment.
                  AUTHORIZATIONS/
                  APPROVALS/
                  NOTIFICATIONS
                  WHERE REQUIRED FOR:
                  -  protocol amendment(s) and other
                   documents
             5.   CURRICULUM VITAE FOR         To document instructions needed to ensure proper storage,
                  NEW INVESTIGATOR(S)          packaging, dispensing and disposition of investigational
                  AND/OR SUBINVESTIGA-TOR(S)   products and trial-related materials
             6.   UPDATES TO NORMAL            To document normal values and ranges that are revised
                  VALUE(S)/RANGE(S) FOR        during the trial
                  MEDICAL/LABORATORY/ TECHNICAL
                  PROCEDURE(S)/TEST(S) INCLUDED
                  IN THE PROTOCOL

             7    UPDATES OF MEDICAL/          To document that tests remain adequate throughout the trial
                  LABORATORY/TECHNICAL         period
                  PROCEDURES/TESTS
                  (where required)
             8.   DOCUMENTATION OF             To document shipment dates, batch numbers and method
                  INVESTIGATIONAL PRODUCT(S)   of shipment of investigational product(s) and trial- related
                  AND TRIAL RELATED MATERIALS   materials. Allows tracking of product batch, review of shipping
                  SHIPMENT                     conditions, and accountability



                                                  NIH Guidelines for Conducting Research in MOH, 2021  49
   60   61   62   63   64   65   66   67   68   69   70